BT1718

Modify Date: 2025-08-26 13:34:30

BT1718 Structure
BT1718 structure
Common Name BT1718
CAS Number 2227366-66-5 Molecular Weight 3511.39
Density N/A Boiling Point N/A
Molecular Formula C159H218ClN31O47S5 Melting Point N/A
MSDS N/A Flash Point N/A

 Use of BT1718


BT1718 is a bicyclic anticancer peptide targeting MT1-MMP. BT1718 uses MT1-MMP to target tumors and promote delivery of the cytotoxic payload Mertansine (HY-19792). BT1718 is a bicycle toxin conjugate with a KD value of 3 nM. MT1-MMP is overexpressed in a variety of advanced solid tumors, including triple-negative breast cancer (TNBC), non-small cell lung cancer[1][2].

 Names

Name BT1718

 BT1718 Biological Activity

Description BT1718 is a bicyclic anticancer peptide targeting MT1-MMP. BT1718 uses MT1-MMP to target tumors and promote delivery of the cytotoxic payload Mertansine (HY-19792). BT1718 is a bicycle toxin conjugate with a KD value of 3 nM. MT1-MMP is overexpressed in a variety of advanced solid tumors, including triple-negative breast cancer (TNBC), non-small cell lung cancer[1][2].
Related Catalog
Target

MMP14

References

[1]. Gowland C, et al. Development of a LC-MS/MS method for the quantification of toxic payload DM1 cleaved from BT1718 in a Phase I study. Bioanalysis. 2021 Jan;13(2):101-113.  

[2]. Helen Harrison, et al. BT1718, a novel bicyclic peptide-maytansinoid conjugate targeting MT1-MMP for the treatment of solid tumors: Design of bicyclic peptide and linker selection.Cancer Research 77(13 Supplement) 2017 July:5144-5144

 Chemical & Physical Properties

Molecular Formula C159H218ClN31O47S5
Molecular Weight 3511.39
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.